Results 121 to 130 of about 444 (134)

Retention and excretion of 32P following ingestion of 32P ATP.

Health physics, 1984
openaire   +1 more source

THE FATE OF 32P-LABELLED BACTERIAL LIPOPOLYSACCHARIDE IN LABORATORY ANIMALS

Lancet, The, 1956
C R Jenkin, J G Howard
exaly  

The enzymatic preparation of [alpha-32P]ATP, [alpha-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases.

Advances in cyclic nucleotide research, 1979
R A, Johnson, T F, Walseth
openaire   +1 more source

The comparative plant availability of 32P myo‐inositol hexaphospha.te and KH2 32PO4 added to soils

Communications in Soil Science and Plant Analysis, 1971
exaly  

32P for myelomatosis.

Nordisk medicin, 2000
openaire   +1 more source

The half-life of 32P

The International Journal of Applied Radiation and Isotopes, 1969
openaire   +1 more source

EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases

European Journal of Nuclear Medicine and Molecular Imaging, 2007
exaly  

[Treatment of polycythemia with 32P].

Meditsinskaia radiologiia, 1986
N, Vlakhov, D, Parusheva, K, Kostov
openaire   +1 more source

Treatment of malignant pericardial effusion with 32P-colloid

British Journal of Cancer, 1999
exaly  

Preparation of 32P-labeled inositol hexaphosphate

Analytical Biochemistry, 1970
openaire   +2 more sources